FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q48449663> ?p ?o ?g. }

• Q48449663 description "2012 nî lūn-bûn" @default.
• Q48449663 description "2012年の論文" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年学术文章" @default.
• Q48449663 description "2012年學術文章" @default.
• Q48449663 description "2012年學術文章" @default.
• Q48449663 description "2012年學術文章" @default.
• Q48449663 description "2012年學術文章" @default.
• Q48449663 description "2012年學術文章" @default.
• Q48449663 description "2012년 논문" @default.
• Q48449663 description "article científic" @default.
• Q48449663 description "article scientific" @default.
• Q48449663 description "article scientifique" @default.
• Q48449663 description "articol științific" @default.
• Q48449663 description "articolo scientifico" @default.
• Q48449663 description "artigo científico" @default.
• Q48449663 description "artigo científico" @default.
• Q48449663 description "artigo científico" @default.
• Q48449663 description "artikel ilmiah" @default.
• Q48449663 description "artikull shkencor" @default.
• Q48449663 description "artikulong pang-agham" @default.
• Q48449663 description "artykuł naukowy" @default.
• Q48449663 description "artículo científico publicado en 2012" @default.
• Q48449663 description "artículu científicu" @default.
• Q48449663 description "bilimsel makale" @default.
• Q48449663 description "bài báo khoa học" @default.
• Q48449663 description "naučni članak" @default.
• Q48449663 description "scienca artikolo" @default.
• Q48449663 description "scientific article published on 26 April 2012" @default.
• Q48449663 description "scientific article published on 26 April 2012" @default.
• Q48449663 description "scientific article published on 26 April 2012" @default.
• Q48449663 description "teaduslik artikkel" @default.
• Q48449663 description "tieteellinen artikkeli" @default.
• Q48449663 description "tudományos cikk" @default.
• Q48449663 description "vedecký článok" @default.
• Q48449663 description "vetenskaplig artikel" @default.
• Q48449663 description "videnskabelig artikel" @default.
• Q48449663 description "vitenskapelig artikkel" @default.
• Q48449663 description "vitskapeleg artikkel" @default.
• Q48449663 description "vědecký článek" @default.
• Q48449663 description "wetenschappelijk artikel" @default.
• Q48449663 description "wissenschaftlicher Artikel" @default.
• Q48449663 description "επιστημονικό άρθρο" @default.
• Q48449663 description "мақолаи илмӣ" @default.
• Q48449663 description "наукова стаття, опублікована у квітні 2012" @default.
• Q48449663 description "научна статия" @default.
• Q48449663 description "научная статья" @default.
• Q48449663 description "научни чланак" @default.
• Q48449663 description "научни чланак" @default.
• Q48449663 description "מאמר מדעי" @default.
• Q48449663 description "مقالة علمية نشرت في 26 أبريل 2012" @default.
• Q48449663 description "২৬ এপ্রিল ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q48449663 description "บทความทางวิทยาศาสตร์" @default.
• Q48449663 description "სამეცნიერო სტატია" @default.
• Q48449663 name "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 name "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 type Item @default.
• Q48449663 label "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 label "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 prefLabel "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 prefLabel "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 P1433 Q48449663-60E3FFA4-9FD0-4DC1-B083-EE283EC8E5A6 @default.
• Q48449663 P1476 Q48449663-5A6EC467-2EC2-4807-828C-4E3B9BF6219C @default.
• Q48449663 P2093 Q48449663-073CD993-96C9-4A86-A292-3018F98E919F @default.
• Q48449663 P2093 Q48449663-1A57166B-D016-4BA6-8549-38AEA1212FBF @default.
• Q48449663 P2093 Q48449663-379B6F4A-1E89-4782-B5D4-0066EDA0CE4D @default.
• Q48449663 P2093 Q48449663-4267974E-56EA-450A-9780-DEE441721957 @default.
• Q48449663 P2093 Q48449663-4B1AEA0E-BD06-49EC-87BF-DDDF0E97DF37 @default.
• Q48449663 P2093 Q48449663-660A32D1-2945-4007-B318-536FE974F7D6 @default.
• Q48449663 P2093 Q48449663-7A29A67E-0299-4B33-9652-4544D02C21D3 @default.
• Q48449663 P2093 Q48449663-7D7CC562-3D7D-4E7B-A4E6-49B6EDCF8FE8 @default.
• Q48449663 P2093 Q48449663-84BA51A4-0215-4E62-BD27-C8BD3283AF31 @default.
• Q48449663 P2093 Q48449663-8A294CC8-3F9B-45BC-9E1A-174EBC6853F9 @default.
• Q48449663 P2093 Q48449663-91D4EE63-492C-4DEC-8552-DF046E4F5B5B @default.
• Q48449663 P2093 Q48449663-B40620E8-6FF1-4156-B5EE-30CF6324D8AD @default.
• Q48449663 P2093 Q48449663-FE64FDE9-BE40-433E-BA1A-AF990FCE650E @default.
• Q48449663 P2093 Q48449663-FEE877F8-F54B-4B5B-99D9-65A8230EF595 @default.
• Q48449663 P304 Q48449663-BC78A4C9-F4AE-49C9-BEFE-9E532E21B841 @default.
• Q48449663 P31 Q48449663-6EB130A9-CC1D-46C6-9D1D-C2191316983B @default.
• Q48449663 P356 Q48449663-A67B0BD0-7D41-440E-A364-D17E9B1EFA3C @default.
• Q48449663 P433 Q48449663-FBCB74B9-8317-4989-82F1-D3D6654D388F @default.
• Q48449663 P478 Q48449663-E5D3C941-FA5D-4FBA-890F-7AFFC9E753BA @default.
• Q48449663 P50 Q48449663-74DA0080-B3F4-44D9-9A53-62DE4CC02AFF @default.
• Q48449663 P577 Q48449663-EB9CDA2F-B19A-4BFF-89C4-00F70B5A3560 @default.
• Q48449663 P5875 Q48449663-FB189CDF-A4E2-4690-B0E7-36F85738B02D @default.
• Q48449663 P698 Q48449663-46C0910C-EF7C-4C77-9F04-E00E5815E114 @default.
• Q48449663 P921 Q48449663-8A77F465-F227-4E4C-9177-CDAA50730F80 @default.
• Q48449663 P356 MDS060 @default.
• Q48449663 P698 22539562 @default.
• Q48449663 P1433 Q326122 @default.
• Q48449663 P1476 "First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG." @default.
• Q48449663 P2093 "A B Lopez" @default.
• Q48449663 P2093 "E Aavall-Lundquvist" @default.
• Q48449663 P2093 "E Eisenhauer" @default.
• Q48449663 P2093 "E Vrdoljak" @default.
• Q48449663 P2093 "G B Kristensen" @default.

• next